🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users administering products of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Removal

According to TikTok, the platform has removed problematic content and banned associated keywords and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive reviews and detailed guides for preparing or administering at home.

After moments of joining one group, a seller posted contact information, where the majority of purchases occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Product Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Although the research behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to potentially serious medical dangers”.